// App-Quantinova.ai

: TMOD-35. CAN RARE SOX9-POSITIVE CELLS INCITE MYC-DRIVEN MEDULLOBLASTOMA RECURRENCE?

Researchers

Presenter

  • Rebecca M Hill

Principal Investigators

  • Adrian M Dubuc

  • Marc Remke

  • Matko aner

  • Vijay Ramaswamy

  • Steve Clifford

  • Olle Sangfelt

  • Ulrich Schller

  • Michael Taylor

  • Robert Wechsler-Reya

  • Holger Weishaupt

  • Fredrik Swartling

Medical Centers

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

  • Uppsala University Hospital, Uppsala, Sweden

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Karolinska Institutet, Stockholm, Sweden

  • University Medical Center Hamburg-Eppendorf, Research Institute Children’s Cancer Center, Hamburg, Germany

  • Hospital for Sick Children, Toronto, ON, Canada

  • Sanford Burnham Prebys Medical Discovery Institute, Heidelberg, CA

Locations

  • United Kingdom

  • Canada

  • Sweden

  • Germany

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • O-6-methylguanine DNA methyltransferase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved